Volumes of activation for dissociation of pentacyanoferrates(II) through pressure and salt effects on reactivity

Summary Dependences of rate constants on pressure (up to 1 kbar) and on added salt concentration (up to 6.0 mol dm^–3 LiNO₃, NaNO₃, NaCl, Na₂SO₄ or KNO₃) have been established for dissociative substitution of pentacyanoferrates(II), [Fe(CN)₅L]^3– with L = 4-cyanopyridine, 4,4-bipyridyl, 4-phenylpyridine and 4-t-butylpyridine. Activation volumes derived directly from pressure effects, and indirectly from salt effects via surface tension dependences and derived surfaces of activation, are reported, compared and discussed.     

Solvatochromism and piezochromism of pentacyanoferrate(II) complexes in binary aqueous solvent media

Summary The solvatochromic behaviour of a number of pentacyano-ferrates (II), [Fe^II(CN)₅L] ^n-, is described, for solutions in H₂O-alcohol, -Me₂CO and -DMSO mixtures. The strong dependence of solvent sensitivity on the nature of the ligand L is particularly fully documented for H₂OMeOH mixtures (0–100% MeOH). The piezochromic behaviour of seven pentacyanoferrates(II) has been established, in aqueous solution. The connection between piezochromism and solvatochromism is detailed, and the solvatochromic results discussed in terms of (preferential) solvation.     

Numerical analysis of dual variable of conductivity in bioconvection flow of Carreau–Yasuda nanofluid containing gyrotactic motile microorganisms over a porous medium

Journal of Thermal Analysis and Calorimetry - The increasing need of the modern era of technology for better ways to increase the heat transfer performance of thermal systems has made nanoliquids...     

Formulation of Piperine–Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation

The present research work is designed to prepare and evaluate piperine liposomes and piperine–chitosan-coated liposomes for oral delivery. Piperine (PPN) is a water-insoluble bioactive compound used for different diseases. The prepared formulations were evaluated for physicochemical study, mucoadhesive study, permeation study and in vitro cytotoxic study using the MCF7 breast cancer cell line. Piperine-loaded liposomes (PLF) were prepared by the thin-film evaporation method. The selected liposomes were coated with chitosan (PLFC) by electrostatic deposition to enhance the mucoadhesive property and in vitro therapeutic efficacy. Based on the findings of the study, the prepared PPN liposomes (PLF3) and chitosan coated PPN liposomes (PLF3C1) showed a nanometric size range of 165.7 ± 7.4 to 243.4 ± 7.5, a narrow polydispersity index (>0.3) and zeta potential (−7.1 to 29.8 mV). The average encapsulation efficiency was found to be between 60 and 80% for all prepared formulations. The drug release and permeation study profile showed biphasic release behavior and enhanced PPN permeation. The in vitro antioxidant study results showed a comparable antioxidant activity with pure PPN. The anticancer study depicted that the cell viability assay of tested PLF3C2 has significantly (p < 0.001)) reduced the IC₅₀ when compared with pure PPN. The study revealed that oral chitosan-coated liposomes are a promising delivery system for the PPN and can increase the therapeutic efficacy against the breast cancer cell line.     

Synthesis of Nanoporous Ni‐Co Mixed Oxides by Thermal Decomposition of Metal‐Cyanide Coordination Polymers

A straightforward strategy to prepare nanoporous metal oxides with well‐defined shapes is highly desirable. Through thermal treatment and a proper selection of metal‐cyanide coordination polymers, nanoporous nickel‐cobalt mixed oxides with different shapes (i.e., flakes and cubes) can be easily prepared. Our nanoporous materials demonstrate high electrocatalytic activity for oxygen evolution reaction.     

Solvation of ethylmaltol and of its iron(III) complex

Summary Solubilities of tris(ethylmaltolato)iron(III) (ethylmaltol = 3-hydroxy-2-ethyl-4-pyrone) were measured in MeOH-H₂O, t-BuOH-H₂O and diol-H₂O mixtures, and in several primary alcohols. Solvation of the ethylmaltol ligand and of two 4-pyridinone analogues has been investigated through solubility measurements in MeOH- H₂O and in t-BuOH-H₂O mixtures, and in a series of primary alcohols. The solvation characteristics of these compounds are compared with those of the parent maltol, its iron(III) complex and a number of other nonelectrolytes.     

Discovery,Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

The COVID-19 pandemic needs no introduction at present. Only a few treatments are available for this disease, including remdesivir and favipiravir. Accordingly, the pharmaceutical industry is striving to develop new treatments for COVID-19. Molnupiravir, an orally active RdRp inhibitor, is in a phase 3 clinical trial against COVID-19. The objective of this review article is to enlighten the researchers working on COVID-19 about the discovery, recent developments, and patents related to molnupiravir. Molnupiravir was originally developed for the treatment of influenza at Emory University, USA. However, this drug has also demonstrated activity against a variety of viruses, including SARS-CoV-2. Now it is being jointly developed by Emory University, Ridgeback Biotherapeutics, and Merck to treat COVID-19. The published clinical data indicate a good safety profile, tolerability, and oral bioavailability of molnupiravir in humans. The patient-compliant oral dosage form of molnupiravir may hit the market in the first or second quarter of 2022. The patent data of molnupiravir revealed its granted compound patent and process-related patent applications. We also anticipate patent filing related to oral dosage forms, inhalers, and a combination of molnupiravir with marketed drugs like remdesivir, favipiravir, and baricitinib. The current pandemic demands a patient compliant, safe, tolerable, and orally effective COVID-19 treatment. The authors believe that molnupiravir meets these requirements and is a breakthrough COVID-19 treatment.     

CoFe-LDH nanowire arrays on graphite felt: A high-performance oxygen evolution electrocatalyst in alkaline media

Developing non-noble-metal oxygen evolution reaction(OER) electrocatalysts with high performance is critical to electrocatalytic water splitting. In this work, we fabricated Co Fe-layered double hydroxide(LDH) nanowire arrays on graphite felt(Co Fe-LDH/GF) via a hydrothermal method. The Co Fe-LDH/GF, as a robust integrated 3 D OER anode, exhibits excellent catalytic activity with the need of low overpotential of 252 and 285 m V to drive current densities of 10 and 100 m A/cm2 in 1.0 mol/L KOH, r...     

Using artificial neural networks to predict the rheological behavior of non-Newtonian graphene–ethylene glycol nanofluid

Journal of Thermal Analysis and Calorimetry - The ability of the artificial neural network (ANN) to predict the viscosity of graphene nanosheet/ethylene glycol ( $$\mu_{{\text{Gr/EG}}}$$ ) was...     

Periodically Arranged Arrays of Dendritic Pt Nanospheres Using Cage‐Type Mesoporous Silica as a Hard Template

Dendritic Pt nanospheres of 20 nm diameter are synthesized by using a highly concentrated surfactant assembly within the large‐sized cage‐type mesopores of mesoporous silica (LP‐FDU‐12). After diluting the surfactant solution with ethanol, the lower viscosity leads to an improved penetration inside the mesopores. After Pt deposition followed by template removal, the arrangement of the Pt nanospheres is a replication from that of the mesopores in the original LP‐FDU‐12 template. Although it is well known that ordered LLCs can form on flat substrates, the confined space inside the mesopores hinders surfactant self‐organization. Therefore, the Pt nanospheres possess a dendritic porous structure over the entire area. The distortion observed in some nanospheres is attributed to the close proximity existing between neighboring cage‐type mesopores. This new type of nanoporous metal with a hierarchical architecture holds potential to enhance substance diffusivity/accessibility for further improvement of catalytic activity.